Literature DB >> 23449495

Irritable bowel syndrome: a review and update.

Kaitlin Occhipinti1, James W Smith.   

Abstract

The understanding of irritable bowel syndrome (IBS) has undergone a rapid evolution with scientific advancement. IBS is a common functional bowel disorder that generates a significant health care burden and is the most commonly diagnosed gastrointestinal condition. There are well-established diagnostic criteria and algorithms for the initial evaluation of patients presenting with the symptoms of IBS. The symptoms can be targeted for therapy with a variety of pharmaceutical and nonpharmaceutical agents. Therapy should be individualized for the patient, and the cornerstone for any effective treatment strategy should be the solid patient-physician relationship.

Entities:  

Keywords:  functional gastrointestinal disease; irritable bowel syndrome

Year:  2012        PMID: 23449495      PMCID: PMC3348735          DOI: 10.1055/s-0032-1301759

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  38 in total

1.  Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome.

Authors:  T Poynard; C Regimbeau; Y Benhamou
Journal:  Aliment Pharmacol Ther       Date:  2001-03       Impact factor: 8.171

Review 2.  The irritable bowel syndrome.

Authors:  B J Horwitz; R S Fisher
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

Review 3.  Treatment of irritable bowel syndrome: a review of randomised controlled trials.

Authors:  R Akehurst; E Kaltenthaler
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

4.  Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.

Authors:  M Pimentel; E J Chow; H C Lin
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

5.  Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Authors:  Mark Pimentel; Anthony Lembo; William D Chey; Salam Zakko; Yehuda Ringel; Jing Yu; Shadreck M Mareya; Audrey L Shaw; Enoch Bortey; William P Forbes
Journal:  N Engl J Med       Date:  2011-01-06       Impact factor: 91.245

6.  Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial.

Authors:  Jessica R Biesiekierski; Evan D Newnham; Peter M Irving; Jacqueline S Barrett; Melissa Haines; James D Doecke; Susan J Shepherd; Jane G Muir; Peter R Gibson
Journal:  Am J Gastroenterol       Date:  2011-01-11       Impact factor: 10.864

Review 7.  The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review.

Authors:  Brooks D Cash; Philip Schoenfeld; William D Chey
Journal:  Am J Gastroenterol       Date:  2002-11       Impact factor: 10.864

8.  The impact of irritable bowel syndrome on health-related quality of life.

Authors:  I M Gralnek; R D Hays; A Kilbourne; B Naliboff; E A Mayer
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

Review 9.  Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials.

Authors:  J Jailwala; T F Imperiale; K Kroenke
Journal:  Ann Intern Med       Date:  2000-07-18       Impact factor: 25.391

10.  Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care.

Authors:  D S Sanders; M J Carter; D P Hurlstone; A Pearce; A M Ward; M E McAlindon; A J Lobo
Journal:  Lancet       Date:  2001-11-03       Impact factor: 79.321

View more
  22 in total

Review 1.  Irritable bowel syndrome: a clinical review.

Authors:  Rosa L S Soares
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

2.  Evaluation of the effect of 1,3-bis-(4-phenyl-[1,2,3] triazole-1-il)2-propanol in comparison with metronidazole in an in vitro culture of Blastocystis in samples of patients with irritable bowel syndrome.

Authors:  L García-Flores; J G Santillán-Benítez; E Cuevas-Yáñez; P Caballero-Vásquez; S Zamudio-Chávez; E Morales-Ávila
Journal:  J Parasit Dis       Date:  2019-05-02

Review 3.  All that a physician should know about FODMAPs.

Authors:  Wajiha Mehtab; Ashish Agarwal; Namrata Singh; Anita Malhotra; Govind K Makharia
Journal:  Indian J Gastroenterol       Date:  2019-12-04

4.  Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China.

Authors:  Chengjiao Yao; Yilin Li; Lihong Luo; Fengjiao Xie; Qin Xiong; Tinglin Li; Chunrong Yang; Pei-Min Feng
Journal:  Dig Dis Sci       Date:  2022-05-03       Impact factor: 3.199

5.  The Effects of Pythagorean Self-Awareness Intervention on Irritable Bowel Syndrome Patients: A Non-randomized Controlled Trial.

Authors:  Kleopatra Gorgili; Artemios Artemiadis; Flora Bacopoulou; Pantelis Karatzas; Xanthi Tigani; Dimitrios Vlachakis; Ioulia Kokka; Liza Varvogli; George P Chrousos; Christina Darviri
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine.

Authors:  Lekha Saha
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

Review 7.  Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis.

Authors:  Guillaume Fond; Anderson Loundou; Nora Hamdani; Wahid Boukouaci; Aroldo Dargel; José Oliveira; Matthieu Roger; Ryad Tamouza; Marion Leboyer; Laurent Boyer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-04-06       Impact factor: 5.270

8.  Epidemiological features of irritable bowel syndrome and its subtypes among Iranian adults.

Authors:  Ammar Hassanzadeh Keshteli; Babak Dehestani; Hamed Daghaghzadeh; Peyman Adibi
Journal:  Ann Gastroenterol       Date:  2015 Apr-Jun

9.  Gene Expression Profiling and Assessment of Vitamin D and Serotonin Pathway Variations in Patients With Irritable Bowel Syndrome.

Authors:  Christopher M Dussik; Maryam Hockley; Aleksandra Grozić; Ichiro Kaneko; Lin Zhang; Marya S Sabir; Jin Park; Jie Wang; Cheryl A Nickerson; Steven H Yale; Christopher J Rall; Amy E Foxx-Orenstein; Connie M Borror; Todd R Sandrin; Peter W Jurutka
Journal:  J Neurogastroenterol Motil       Date:  2018-01-30       Impact factor: 4.924

10.  Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome.

Authors:  Jingguo Gao
Journal:  Exp Ther Med       Date:  2013-05-08       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.